SEC Form 4 · accession 0000874015-18-000132
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth L Hougen
Officer — SVP, Finance & CFO
Period of report
Dec 18, 2018
Accepted (ET)
Dec 20, 2018 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 18, 2018 | M | 2,000 | $7.25 | A | 16,774 | D | |
| Common StockF1 | Dec 18, 2018 | S | 2,000 | $52.00 | D | 14,774 | D | |
| Common StockF1 | Dec 19, 2018 | M | 2,063 | $7.25 | A | 16,837 | D | |
| Common StockF1 | Dec 19, 2018 | S | 2,063 | $52.05 | D | 14,774 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $7.25 | Dec 18, 2018 | M | 2,000 | A | Jan 3, 2016 | Jan 2, 2019 | Common Stock | 2,000 | 2,063 | D |
| Employee Stock Option (right to buy) | $7.25 | Dec 19, 2018 | M | 2,063 | A | Jan 3, 2016 | Jan 2, 2019 | Common Stock | 2,063 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 11/07/2018.